［1］Lenard NR,Berthoud HR.Central and peripheral regulation of food intake and physical activity: pathways and genes［J］.Obesity, 2008, 16(13):11-22.
［2］Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications［J］.Arq Bras Endocrinol Metabol, 2009, 53(2):120-128.
［3］Vettor R, Fabris R, Pagano C. Federspil G. Neuroendocrine regulation of eating behavior［J］. Endocrinol Invest, 2002, 25(10):836-854.
［4］Wynne K, Stanley S, McGowan B, Bloom S. Appetite control［J］. J Endocrinol, 2005, 184(2):291-318.
［5］King PJ. The hypothalamus and obesity［J］.Curr Drug Targets, 2005, 6(2):225-240.
［6］Bouret SG, Draper SJ, Simerly RB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice［J］.J Neurosci, 2004, 24(11):2797-2805.
［7］Gluck EF, Stephens N, Swoap SJ. Peripheral ghrelin deepens torpor bouts in mice through the arcuate nucleus neuropeptide Y signaling pathway［J］.Am J Physiol Requl Inteqr Comp Physiol, 2006, 291(5):R1303-1309.
［9］Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications［J］. Arq Bras Endocrinol Metabol, 2009, 53(2):120-128.
［10］Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis:lifting the lid on a black box［J］.Proc Nutr Soc, 2000, 59(3):385-396.
［11］Monyer H, Markram H. Interneuron diversity series:molecular and genetic tools to study GABAergic interneuron diversity and function［J］.Trends Neurosci, 2004, 27(2):90-97.
［12］Woods SC, Seeley RJ. Hap1 and GABA:thinking about food intake［J］.Cell Metab, 2006, 3(6):388-390.
［13］Meister B. Control of food intake via leptin receptors in the hypothalamus［J］. Vitam Horm, 2000, 59:265-304.
［14］Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M, et al. A role for the endogenous opioid beta-endorphin in energy homeostasis［J］. Endocrinology, 2003, 144(5):1753-1760.
［15］Inui T, Shimura T, Yamamoto T. The role of the ventral pallidum GABAergic system in conditioned taste aversion:effects of microinjections of a GABAA receptor antagonist on taste palatability of a conditioned stimulus［J］. Brain Res, 2007, 20(1164):117-124．
［16］Kehoe P, Sakurai S. Preferred tastes and opioid-modulated behaviors in neonatal rats［J］. Dev Psychobiol, 1991, 24(2):135-148.
［17］Saggio LL, Drucker DJ. Clincal endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2［J］.Best Pract Res Clin Endocrinol Metab, 2004, 18(4):531-554.
［18］Wang Q, Li L, Xu E, Wong V, Rhodes C, Brubaker PL. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells［J］.Diabetologia, 2004, 47(3):478-487.
［19］Heinrichs SC, Li DL, Iyengar S. Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats［J］. Brain Res, 2001, 900(2):177-185.
［20］Boules M, Cusack B, Zhao L, Fauq A, McCormick DJ, Richelson E. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents［J］.Brain Res, 2000, 865(1):35-44.
［21］Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY (3-36) physiologically inhibits food intake［J］. Nature, 2002, 418(6898):650-654.
［22］Onaga T, Zabielski R, Kato S. Multiple regulation of peptide YY secretion in the digestive tract［J］.Peptides, 2002, 23(2):279-290.
［23］Hira T, Takahashi K, Hara H. Sucrose fatty acid esters suppress pancreatic secretion accompanied by peptide YY release in pancreaticobiliary diverted rats［J］.Exp Physiol, 2007, 92(4):687-694.
［24］Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K, et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats［J］. Endocrinology, 2005, 146(5):2369-2375.
［25］Blevins JE, Stanley BG, Reidelberger RD. Brain regions where cholecystokinin suppresses feeding in rats［J］.Brain Res, 2000, 860(12):1-10.
［26］Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K, et al. Cholecystoki-nin activates orexin/hypocretin neurons through the cholecystokinin A receptor［J］. J Neurosci, 2005, 25(32):7459-7469.
［27］Yuan CS, Attele AS, Dey L, Xie JT. Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats［J］. J Pharmacol Exp Ther, 2000, 295(1):177-182.
［28］Palou M, Sánchez J, Rodríguez AM, Priego T, Picó C, Palou A. Induction of NPY/AgRP orexigenic peptide expression in rat hypothalamus is an early event in fasting: relationship with circulating leptin, insulin and glucose［J］.Cell Physiol Biochem, 2009, 23(1-3):115-124.
［29］Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight［J］.Physiol Behav, 2007, 2(12):263-271.
［30］Wellman PJ. Norepinephrine and the control of food intake［J］.Nutrition, 2000, 16(10):837-842.
［31］Taylor K, Lester E, Hudson B, Ritter S. Hypothalamic and hindbrain NPY, AGRP and NE increase consummatory feeding responses［J］.Physiol Behav, 2007, 90(5):744-750.
［32］Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, et al. Hypothalamic dopamine and serotonin in the regulation of food intake［J］.Nutrition, 2000, 16(10):843-857.
［33］Karagiannides I, Torres D, Tseng YH, Bowe C, Carvalho E, Espinoza D, et al. Substance P as a novel anti-obesity target［J］. Gastroenterology, 2008, 134(3):747-755.
［34］Chaput JP, Tremblay A. The glucostatic theory of appetite control and the risk of obesity and diabetes［J］. Int J Obes, 2009, 33(1):46-53.
［35］Dockray GJ.The versatility of the vagus［J］.Physiol Behav, 2009, 97(5):531-536.
